China is offering employees of some large state-run companies the option of being inoculated with two coronavirus vaccines currently in development, reported Bloomberg.
According to people familiar with the matter, employees intending to travel overseas for work can volunteer to be administered vaccines developed by China National Biotec Group (CNBG), a subsidiary of Sinopharm.
The proposal was relayed to state-owned companies by the government body that oversees them, the people said.
CNBG's experimental vaccines have been tested on 2000 people with no reported "obvious adverse effects," Sinopharm chairman Liu Jingzhen told local media last month.
However, a CNBG spokeswoman said she was not aware of the vaccine offer and declined to comment further.
The news source said there are currently five Chinese vaccine candidates in the clinical testing stage, competing with products being developed by global companies such as AstraZeneca and Moderna.
To read more NewsPoints articles, click here.